Article

Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis

2018-08-13

Abstract excerpt

Genome wide association studies have identified >200 susceptibility loci accounting for much of the heritability of Multiple Sclerosis (MS). Epstein Barr virus (EBV), a memory B cell tropic virus, has been identified as necessary but not sufficient for development of MS, with evidence for disease causation. The molecular and immunological basis for this has not been established. LCL proliferation is driven by sign...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ddf75975-904a-5d7d-adf9-fa08579dc8eb
DOI: 10.1101/390609

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple SclerosisDOI 10.1101/390609Read

Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibilitySemantic proximity Read

Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactomeSemantic proximity Read

The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.Semantic proximity Read

A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosisSemantic proximity Read

The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci.Semantic proximity Read

Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus associationSemantic proximity Read

Identification of multiple sclerosis-related genes regulated by EBV-encoded microRNAs in B cellsSemantic proximity Read

Enhanced EBNA2-dependent activity in EBV-transformed B cells from patients with multiple sclerosisSemantic proximity Read

A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.Semantic proximity Read

The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunitiesSemantic proximity Read

The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis PathogenesisSemantic proximity Read

The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.Semantic proximity Read